Recent observations suggest that the src-related tyrosine protein kinase p59~ may be involved in antigen-induced T lymphocyte activation. As a result of alternative splicing, p59~ exists as two isoforms that differ exclusively within a short sequence spanning the end of the Src Homology 2 (SH2) region and the beginning of the tyrosine protein kinase domain. While one p59~ isoform (fynB) is highly expressed in brain, the alternative product (fynT) is principally found in T lymphocytes. To further understand the role of p59~ in T cell activation and to test the hypothesis that p59~ T serves a tissue-specific function in T lymphocytes, we have examined the effects of expression of activated versions (tyrosine 528 to phenylalanine 528 mutants) of either form of p59~ on the physiology of an antigen-spedfic mouse T cell hybridoma. Our results demonstrated that the two forms offyn, expressed in equivalent amounts, efficiently enhanced antibody-induced T cell receptor (TCR)-mediated signals. In contrast, only p59~ T increased interleukin 2 production in response to antigen stimulation. This finding implies that the distinct p59~ isoform expressed in T lymphocytes regulates the coupling of TCtL stimulation by antigen/major histocompatibility complex to lymphokine production.
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ntigen-induced T lymphocyte activation is primarily mediated by changes in intracellular tyrosine protein phosphorylation (for review, see reference 1). Although the cellular machinery regulating this biochemical signal remains poorly characterized, recent observations suggest that the srerelated nonreceptor tyrosine protein kinases p56 ~ and p59~ are involved in this process, p56 lck is a lymphocyte-specific tyrosine protein kinase associated with and regulated by the CD4 and CD8 T cell surface antigens (for review, see reference 2). Increasing evidence demonstrates that a large part of the accessory function provided by CD4 or CD8 during T cell activation is mediated through p561r Contrary to p56 lCk, p59~ is expressed in most cell types (3) (4) (5) (6) . It is interesting that as a result of alternative splicing of mutually exclusive exons 7, p59~ exists as two isoforms differing solely within a stretch of 51 amino acids spanning the end of the SH21 region and the beginning of an otherwise classical tyrosine protein kinase domain (see Fig. 1 A) (7) . It has been postulated that as a consequence of different substrate specificities and/or catalytic efl~ciencies, these two enzymes regulate distinct cellular processes.
Whereas onefyn isoform 0CynB) accumulates highly in brain, the other (fynT) is expressed predominantly in T lymphocytes (7; L. M. L. Chow, A. Veillette, D. Davidson, unpublished data). The limited homology (53% or less) between the exon 7-encoded sequences offynT and those off, B, as well as of all other src-related tyrosine protein kinases, fostered the early view that p59~ T plays a specialized role in T lymphocyte physiology. The subsequent demonstration that a fraction of p59~ T is physically associated with elements of the TCR complex suggested that this polypeptide may in fact regulate antigen receptor-induced signals (8) . Additional support for this possibility was recently provided by the observation that thymocytes of transgenic mice overexpressing either p59~ isoform showed enhanced TCR-induced tyrosine protein phosphorylation, calcium response, and 11.-2 production (9). However, no significant difference between the functions of p59 fy~ and p59 fy~ were noted in this study.
supplemented with 10% FCS (Gibco Laboratories, Grand Island, NY), penicillin, and streptomycin. Note that specific ribonuclease protection assays showed that parental BI-141 cells e~clusively expressfynT transcripts (L. M. L. Chow, A. Veillette, and D. Davidson, unpublished observations). The IL-2--dependent HT-2 indicator cells (11) were cultured in RPMI 1640 medium supplemented as mentioned above, and also containing 50 U/ml rlL-2 and 55/~M B-ME (Gibco Laboratories). FT 5.7 cells are L fibroblasts expressing the hybrid class II MHC molecule A~A~ (kindly provided by Ron Germain, National Institutes of Health, Bethesda, MD). They were grown in HAT-supplemented alpha MEM containing 10% FCS and antibiotics. All cells were maintained at 37~ in a humidified COz incubator.
Site-directed Mutagenesis. Wild-type murinefynT (MM23) and fynB (MB1) complementary DNAs (cDNAs) were provided by M. P. Cooke and R. M. Perlmutter (University of Washington, Seattle, WA) (7). All mutations were introduced by oligonucleotidedirected mutagenesis of uracil-enriched double-stranded plasmid DNA, as described by Slilaty et al. (12) . Initially, an EcoRI site was introduced at position 210 of the 5' untranslated (UT) region of the fynT cDNA MM23 (using the oligonucleotide 5'AAGC-TCCCGAATTCCCACCAACTY). This allowed subsequent removal of most of the 5' UT sequences of MM23 through standard rDNA technology. As this portion of the cDNA contains multiple AUG codons, it may repress the translation offyn mRNAs (13) . Then, to generate activated versions of p59~, tyrosine 528 was mutated to a phenylalanine using the oligonucleotide 5'CGGGCTGAAACTG~Y. The mutant fynB cDNA was created by e~hanging the ApaI-BamHI fragment of MM23 (which contains the seventh exon) with that of thefynB cDNA MB1. All exchanged fragments were fully resequenced and found to contain no additional mutations (data not shown). Similarly kinase-negative variants of F528 p59~T and F528 p59~ were engineered by introducing a lysine to methionine substitution at position 296 of the ATP-binding site of these polypeptides using oligonucleotidedirected mutagenesis (mutagenic oligonucleotide: 5'TAAGGGT-CATTATGGCTY). An identical mutation in other tyrosine protein kinases has been shown to abolish catalytic activity (14) . After fully resequencing to ensure that no additional mutations were introduced, the smallest restriction fragments containing the mutated nucleotide were substituted for the equivalent fragments in the activated fyn cDNAs.
Retroviral Expression Vectors. Fyn-s~cific IraraunoblotAssay. Equivalent numbers of ceils were lysed in sample buffer and tysates resolved on 8% SDS-PAGE gels. Subsequent immunoblotting was conducted as described previously (19) , using a rabbit anti-fyn serum generated by immunization with a trpE fusion protein containing residues 25-141 of the murine p59~ sequence (7) . This peptide corresponds to sequences located within the unique and Src Homology 3 (SH3) domains of p59~, which are therefore common to fynT and fynB. This antiserum specifically recognized p59~ in both immunoprecipitation and immunoblot assays. It did not react with p56 ~k (our unpublished data). For quantitation, bands were cut from nitrocellulose and counted in a gamma counter. The presence of equivalent amounts of proteins in each lane was subsequently confirmed by staining of nitrocellulose filters with amido black.
Antibody-mediated Cross-linking and Antiphospkotyrosine Iramuno. blots. These assays were done as described elsewhere (20, 21) . The anti-TCR and -CD3 mAbs have been reported previously (22) (23) (24) . Titration of the amount of mAb F23.1 used for cross-linking revealed that the antibody-ioduced tyrosine protein phosphorylation dose-responses were similar for F528 p59~T and F528 p59~ expressing cells (unpublished observations). Antibody-mediated crosslinking was also performed using biotinylated primary antibodies and avidin. Incubation with avidin was for 5 rain. Biotinylated antiTCIk mAb F23.1 and anti-CD45 mAb 30-Fll were kindly provided by Jeff Ledbetter (Bristol-Myers-Squibb, Seattle, WA). Antiphosphotyrosine immunoblotting was performed using afflnity-purified polyclonal rabbit anti-phosphotyrosine antibodies (our unpublished data). Quantitation was performed as outlined above. (25) . After incubation at 370C for 24 h, supernatants were collected and assayed for II:2 content as described above. Controls were without any addition.
Results
To better understand the role of p59% T in mature T cell physiology, we have introduced constitutively activated versions of murine p59~ T and p59% B in the CD4-negative, class II MHC-restricted beef insulin-specific murine helper T cell bybridoma BI-141 (10). These activatedfyn polypeptides were generated by mutating a COOH-terminal site of tyrosine phosphorylation (tyrosine 528) to a phenylalanine residue, which cannot be phosphorylated (F528 p59~ mutants; Fig. 1 A) . Phosphorylation of this conserved tyrosine residue represses the enzymatic function of src-related tyrosine protein kinases (26; for review, see reference 27). Cells were selected for resistance to the aminoglycoside G418 and individual clones isolated by limiting dilution. Clones were first assayed for expression of the appropriate retroviral transcript by Northern blot analysis (Fig. 1 B) . Four cell lines expressing comparable levels of either of the two mutantfyn tLNAs ( Fig. 1 B, lanes 3-6 and 7-10 ) were randomly selected for further studies. BI-141 cell lines expressing the neomycin marker alone (Neo; Fig. 1 B, lane 2) or comparable amounts of transcripts encoding an activated version of p56 Ic~ (F505 p56~; Fig. 1 B, lanes II-I3) (16) were also included in these analyses. A subsequentfyn-specific immunoblot assay revealed that F528 p59~ expressing cells ( Fig. 1 C, lanes 4-11) contained 1.5-3 times more p59~ than parental BI-141 cells ( Fig. 1 C, lane 1) or control Neo dones ( Fig. 1 C, lanes 2  and 3) . This level of overexpression most likely reflects the high levels of endogenous p59 fynv in BI-141 cells. All cell lines expressed levels of TCR, CD3, Thyl.2, CD45, and p56 lck that were identical to those of parent BI-141 cells. Moreover, all clones remained CD4-negative (data not shown).
Tyrosine protein phosphorylation is the earliest biochemical alteration detected after antigen receptor stimulation (1). It is important to note that, as shown by studies using tyrosinespecific protein kinase inhibitors, this signal is a prerequisite for the subsequent increase in intraceUular calcium and IL-2 production (28, 29) . To investigate the ability of the twofyn isoforms to contribute to antigen receptor signaling, the effects of expression of these polypeptides on TCR-induced tyrosine protein phosphorylation were examined using an antiphosphotyrosine immunoblot assay (Fig. 2) . Upon stimulation with anti-TCR mAb F23.1 and rabbit anti-mouse (RAM) IgG, we found that cells expressing F528 p59~ v (Fig. 2 A, lanes 7-12) or F528 p59~ (Fig. 2 A, lanes  13-18) demonstrated more rapid, robust, and sustained tyrosine protein phosphorylation signals than control cells ( Fig.   2 A, lanes I-6) . Similar results were noted after stimulation with anti-TCR mAb H57.597 or anti-CD3 epsilon mAb 145-2Cll (data not shown). Although the pattern and duration of substrate tyrosine phosphorylation were generally the same for cells expressing eitherfyn mutant, quantitative analyses suggested that tyrosine phosphorylation of certain substrates (p70 and p36) was more prolonged in p59~ T than p595'~ expressing cells. Both mutants also augmented baseline tyrosine phosphorylation of polypeptides migrating at 100, 85, 59, and 54 kD. The substrates showing augmented TCRinduced tyrosine phosphorylation in F528 p59~ expressing cells (Fig. 2 B, lanes 5-I2) had the same apparent molecular weights as those previously shown to be regulated by F505 p56 lck (Fig. 2 B, lanes 13-16) (16) . However, the enhancement by F528 p59~ was generally less than that conferred by the activated kk polypeptide.
Previous studies have shown that the CD45 tyrosine phosphatase can significantly modulate antigen receptor-induced signals (1, 2) . This implies that such an enzyme may physiologically regulate the tyrosine protein kinases mediating the TCR-induced signals. Thus, in an attempt to further characterize the mechanisms by which the twofyn isoforms regnlate TCR-induced tyrosine protein phosphorylation, the effects of coaggregation of TCR with CD45 were evaluated (Fig.  2 C) . As is the case for Neo expressing cells (Fig. 2 C, lane   4) , or cells containing F505 p56 lck (Fig. 2 C, lane 16) , coaggregation of TCR with CD45 on F528fynT (Fig. 2 C, lane 8) or F528 fynB (Fig. 2 C, lane 12) expressing cells abrogated anti-TCR antibody-induced tyrosine protein phosphoryhtion ( Fig. 2 C, lanes 3, 7, II, and I5) . Coupled with the findings reported above, this result suggests that the activated p59~ variants, as well as activated p56 lck, regulate antigen receptor-mediated signals through overlapping and possibly similar mechanisms.
We next wanted to ascertain whether the enhancement of TCR-induced signals by fyn resulted in improved lymphokine production (Fig. 3) . To this end, calls were stimulated with anti-TCR mAb F23.1 immobilized on plastic and IL-2 production was assayed using the IL-2-sensitive cell line HT-2 (Fig. 3 A) . When compared with Neo cells, F528 p59~ x and F528 p59 ~a3 expressing cells demonstrated a comparable and marked enhancement of antibody-induced Ib2 production. This was most obvious at low concentrations of antibody (30 and 100 ng/ml), at which no response was noted in control cells. In fact, IL-2 release after stimulation with 30 ng/ml of mAb F23.1 tended to be more substantial for cells expressing F528 p59~ s.
Cell lines were also tested for reactivity to beef insulin presented in association with the appropriate class II MHC molecnles (A~A~). Two assays, representative of a total of eight independent experiments, are shown in Fig. 3 , B and C. These studies revealed that cells expressing F528 p59~ T had significantly improved antigen/MHC-induced IL-2 responses when compared with control Neo cells. Surprisingly, this was not the case for cells expressing equivalent amounts of F528 p596~, which had essentially unaltered responses to antigen (Fig. 3, B and C) . Only one F528 p59~ clone (FynB F18, Fig. 3 C) showed a small but consistent increase in antigen-induced lymphokine production. The improvement of antigen responsiveness by F528 p59~ T was less than that conferred by expression of CD4 or F505 p56 zck in BI-141 cells. A comparison with representative clones is included in the experiment depicted in Fig. 3 C. We finally verified that the enhancement of T cell responsiveness by F528 p59~ was related to the elevated tyrosine protein kinase activity of this mutant. To this effect, F528
fynT and F528fFd/polypeptides with abolished catalytic activity (M296F528 p59~) (Fig. 4) or wild-typefyn proteins (Fig. 5) were expressed in BI-141 cells. Cell lines containing equivalent amounts ofretroviralfyn transcripts were sdected for comparison with F528 p59~ expressing cells (Fig. 4 A, and data not shown). The M296F528 p59~ expressing ceils contained 1.5-2.5-fold higher levels offyn protein than con- -I0) , and, for comparison, F505 p561ck (lanes [11] [12] [13] . ILNA from parental BI-141 cells was also assayed as negative control (lane I). Lanes 1:BI-141 parent; 2: Neo 2; 3: FynT F2; 4: FynT F7; 5: FynT F12; 6: PyrtT F19; 7: FynB F13; 8: FynB F15; 9: FynB F17; 10: FynB F18; 11: Lck F7; 12: Lck F9, and 13: Lck F13. The probe used for hybridization was a 687-bp HindlII-NaeI fragment from pLXSN that encompasses the majority of the neomycin resistance gene (neo) (Fig. 1 A) . trol Neo cells (Fig. 4 B) . These levels were comparable to the amounts detected in F528 p 5 9~ expressing cells. Further analysis by antiphosphotyrosine immunoblot (Fig. 4 C) showed that cells expressing the inactive versions offynT (Fig.   4 C, lanes 5-8) or fynB (Fig. 4 C, lanes 9-I2) had TCRinduced tyrosine phosphorylation signals that were comparable to those of Neo cells (Fig. 4 C, I-4) . Moreover, these cells failed to demonstrate enhanced II-2 responses to stimulation with antigen (Fig. 4/9 ) or anti-TCR antibodies (data not shown). Similarly, the BI-141 derivatives overexpressing wildtypefynT orfynB proteins (Fig. 5 A) did not show improved responsiveness to antigen (Fig. 5, B) . Therefore, lack of the regulatory COOH-terminal site of tyrosine phosphorylation (tyrosine 528) is critical for enhancement of antigen responsiveness by fynT.
Discussion
The results presented in this report show that activated p59~ T and p59 f~ efficiently enhance anti-TCR antibodyinduced responses in the murine T cell hybridoma BI-141. This finding is consistent with the results of others (9) and further implicates p59f~ in the regulation of T cell receptor signaling. It is interesting, however, that even though the two proteins were expressed at equivalent levels, only activated p59~ T efficiently increased T cell responsiveness to antigen stimulation. This observation strongly suggests that fynT serves as a tissue-specific function in T lymphocytes.
It was intriguing to note that despite the distinct effects of p59~ T and p59~ on antigen-induced T cell responses, we failed to detect consistent qualitative or quantitative differences in the ability of these two polypeptides to improve T cell responses to antibody stimulation, induding tyrosine protein phosphorylation and lymphokine production. Consistently, we found that bothfyn isoforms had apparently similar in vitro tyrosine protein kinase activities and seemed capable of physically interacting with the TCK compl~ (D. Davidson and A. Veillette, unpublished observations). Although it 3, 5, 7, 9, 1I, 13, and 15 : RAM IgG alone and lanes 2, 4, 6, 8, 10, 12, 14, and 16: mAb should be noted that distinctions in substrate specificity or catalytic function may have been masked by the stimulation provided by anti-TCR antibodies, an alternative explanation for our results is that the enhancement of TCR-induced tyrosine protein phosphorylation by activatedfyn is insuf~cient to ameliorate response to antigen/MHC stimulation. Through its unique sequences, p59~ T may regulate additional cellular pathways which further modulate T cell responsiveness to antigen/MHC. These yet unidentified targets could be other signal-transducing molecules, adhesion molecules, or cytoskeletal constituents. Although the ranges of overexpression typically allowed by retrovirus-mediated gene transfer did not permit further overexpression of thefyn isoforms in BI-141 cells, it would be of interest to test whether a marked increase in expression of activated fynB in a permissive experimental system could mimic the ability offynT to enhance physiological antigen receptor-mediated responses.
Based on the findings reported herein, we postulate that fynT must participate in regulatory pathways involved in coupling TCR stimulation by antigen/MHC to lymphokine production. It is interesting that a related function was recently ascribed to the ~" chain of the TCR complex (30) . Deletion of the cytoplasmic tail of ~" significantly decreased the ability of this molecule to link antigen/MHC-induced TCR stimulation to lymphokine production. As is the case for p59~ a3, this defect could be bypassed by stimulation with high a~nity anti-TCR mAbs. These provocative similarities suggest that the function provided by the cytoplasmic tail of ~" is mediated either directly or indirectly through p59~ r.
Further support for this view is lent by the observation that a fraction of p59b~T can be found associated with TCR in mild detergent lysates of T lymphocytes (8) .
Our data, as well as other published results (9, 16) , show that activated versions of the two src-related tyrosine protein kinases abundantly expressed in T cells (p59 I~T and p56 kk) can enhance antigen receptor-mediated functions. It is important that this is in contrast with p60 're, a member of the src family not normally expressed in T lymphocytes. Expression of an activated version of this tyrosine protein kinase in antigen-specific T cells fails to improve antigen receptorinduced signals, despite its ability to spontaneously enhance T cell tyrosine protein phosphorylation and lymphokine production (31, and our unpublished data). Whereas the regulatory interactions between p561ok and CD4/CD8 are well established (2), the physiological processes allowing the activation of p59~ in T cells are unfortunately poorly understood. As fynT can associate with TCR, it has been proposed that the enzymatic function of p59~ T is directly regulated by TCR. However, the in vitro catalytic activity of p59~ T is not enhanced upon antibody stimulation of TCR (8, and our unpublished observations). While this finding does not preclude the view that p59~T may be regulated through physical interactions with TCR, it may indicate that the function of this enzyme is controlled through a more complex machinery. For example, fynT may first be activated by CD45-mediated dephosphorylation of tyrosine 528 (1) . Subsequently, as suggested by our observations, TCR stimulation may allow activated p59~ T molecules to effectively interact with and/or phosphorylate their substrates. These events may be prohibited by coaggregation of TCR with CD45, possibly as a result of a decrease in the activity of p59~ T by CD45 approximation, or as a consequence of substrate dephosphorylation. A related model has been proposed for the regulation of the function of activated p56 L:k molecules in T calls (16) . Despite the fact that the basis of these phenomena remains largely undefined, it is becoming increasingly clear that through both distinct, as well as overlapping, regulatory processes, p59~ T and p56 l~ play important roles in the sigual transduction of T cell activation.
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